Transition from insulin to oral sulfonylurea therapy in children with diabetes due to activating mutations in KCNJ11

被引：0
|
作者：
Greeley, Siri Atma W.
Bordini, Brian D.
Edidin, Deborah V.
Littlejohn, Elizabeth E.
Philipson, Louis H.
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A699 / A699
页数：1
相关论文
共 50 条
  • [41] Successful transition to sulfonylurea in neonatal diabetes, developmental delay, and seizures (DEND syndrome) due to R50P KCNJ11 mutation
    Pena-Almazan, Susan
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 108 (01) : E18 - E20
  • [42] Mother and daughter carrying the same KCNJ11 mutation but with a different response to switching from insulin to sulfonylurea
    Russo, Chiara
    Salina, Alessandro
    Aloi, Concetta
    Iafusco, Dario
    Lorini, Renata
    d'Annunzio, Giuseppe
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 94 (02) : E50 - E52
  • [43] STUDY OF KCNJ11 GENE MUTATIONS IN ASSOCIATION WITH MONOGENIC DIABETES OF INFANCY AND RESPONSE TO SULFONYLUREA TREATMENT IN A COHORT STUDY IN EGYPT
    Madani, H. A.
    Fawzy, N.
    Afif, A.
    Abdelghaffar, S.
    Gohar, N.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2016, 12 (02) : 157 - 160
  • [44] Efficacy and Safety of Sulfonylurea Use in Permanent Neonatal Diabetes Due to KCNJ11 Gene Mutations: 34-Month Median Follow-Up
    Klupa, Tomasz
    Skupien, Jan
    Mirkiewicz-Sieradzka, Barbara
    Gach, Agnieszka
    Noczynska, Anna
    Zubkiewicz-Kucharska, Agnieszka
    Szalecki, Mieczyslaw
    Kozek, Elzbieta
    Nazim, Joanna
    Mlynarski, Wojciech
    Malecki, Maciej T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2010, 12 (05) : 387 - 391
  • [45] Fewer Beta Cells and Insulin Granules in Autopsy Histology of a Patient With Sulfonylurea-Unresponsive KCNJ11 Neonatal Diabetes
    Greeley, Siri Atma W.
    Zielinski, Mark C.
    Wood, Jamie R.
    Steiner, Donald F.
    Bell, Graeme I.
    Philipson, Louis H.
    Hara, Manami
    DIABETES, 2013, 62 : A562 - A562
  • [46] KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features
    Anna L Gloyn
    Catherine Diatloff-Zito
    Emma L Edghill
    Christine Bellanné-Chantelot
    Sylvie Nivot
    Régis Coutant
    Sian Ellard
    Andrew T Hattersley
    Jean Jacques Robert
    European Journal of Human Genetics, 2006, 14 : 824 - 830
  • [47] Neonatal Diabetes Mellitus: Description of Two Puerto Rican Children with KCNJ11 Activating Gene Mutation
    Nieves-Rivera, Francisco
    Gonzalez-Pijem, Lilliam
    PUERTO RICO HEALTH SCIENCES JOURNAL, 2011, 30 (02) : 87 - 89
  • [48] KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features
    Gloyn, Anna L.
    Diatloff-Zito, Catherine
    Edghill, Emma L.
    Bellanne-Chantelot, Christine
    Nivot, Sylvie
    Coutant, Regis
    Ellard, Sian
    Hattersley, Andrew T.
    Robert, Jean Jacques
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2006, 14 (07) : 824 - 830
  • [49] Neonatal Diabetes Mellitus Responsive to Sulphonylurea, Due to KCNJ11 Mutation
    Erbes, J. M.
    Garcia, T. S.
    Lee, J. S.
    Cechinel, E.
    Simoni, G.
    Nascimento, M. L.
    Silva, P. C. A.
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 92 : 38 - 39
  • [50] Successful transition from insulin to glyburide in 2 siblings with neonatal diabetes mellitus due to KCNJ11 gene mutation encoding Kir6.2
    Neacsu, Otilia
    Quintos, J. B.
    Phornphutkul, Chanika
    McEachern, Rebecca R.
    HORMONE RESEARCH, 2009, 72 : 327 - 327
12345